Julphar currently has
3,537 products
registered in over 50
countries around the
globe, with more than
809 formulations and 191
brands. These are cross all
the major therapeutic
segments. Out of these,
over 2,120 product
registrations are in the GCC countries, while the
rest span other regions,
mainly countries in the
rest of the Arab world,
Asia, Africa, CIS and
Latin America. Fifty new
product registrations
have taken place during
the year 2010. There is
also a healthy pipeline
of new files under
preparation.
Julphar will likely
continue to go for more
registrations in the
coming years in all the
major markets in the
region, besides
exploring newer markets.
Our future products are
expected to cover all
our existing major
therapeutic segments, as
well as newer segments,
offering more complex
and challenging products
to address newer and
more serious healthcare
threats. All these augur
well for the Brand
Julphar.
